Loading
Latest filing published 17 Mar 2026 for Apyx Medical Corp, €58k. Read the official filing
Moshe Citronowicz discloses dealings in Apyx Medical Corp to SEC (Form 4). Over a trading history stretching from 11 July 2022 to 15 March 2026, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 17 March 2026, the filings show an option exercise worth €58k in Apyx Medical Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations